Status:
COMPLETED
Validation of the NeuroTec Loft
Lead Sponsor:
University of Bern
Collaborating Sponsors:
Insel Gruppe AG, University Hospital Bern
Conditions:
Neurodegenerative Diseases
Activities of Daily Living
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The progression of neurodegenerative disorders and the increasing number of elderly people intensifies the need of institutional care, which contrasts with the desire of most elderly and patients to l...
Detailed Description
The higher prevalence of age-associated neurodegenerative disorders (e.g. Parkinson, Alzheimer), is in line with a steady increase of the average life expectancy in Switzerland. With the progression o...
Eligibility Criteria
Inclusion
- Written informed consent
- Aged ≥18 years
- German speaking
Exclusion
- Infected by multidrug-resistant bacteria according to current medical history
- Incontinence
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 29 2022
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04793555
Start Date
June 1 2021
End Date
July 29 2022
Last Update
August 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ARTORG Center for Biomedical Engineering, Gerontechnology and Rehabilitation
Bern, Ber, Switzerland, 3008